What's in Institut Phoceen de Nephrologie's pipeline?

Institut Phoceen de Nephrologie has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Institut Phoceen de Nephrologie's portfolio?

No competitive overlap detected.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/institut-phoceen-de-nephrologie.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Institut Phoceen de Nephrologie — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Institut Phoceen de Nephrologie pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Cholecalciferol 100.000 UI administration	Cholecalciferol 100.000 UI administration	phase 3	Vitamin D analog / Nutritional supplement	Vitamin D receptor (VDR)	Nephrology / Mineral metabolism / Immunology

Therapeutic area mix

Nephrology / Mineral metabolism / Immunology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for Institut Phoceen de Nephrologie:

Cite this brief

Drug Landscape (2026). Institut Phoceen de Nephrologie — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/institut-phoceen-de-nephrologie. Accessed 2026-05-16.